C
CERO//CIK 0001870404
CERO THERAPEUTICS HOLDINGS, INC.
Market Data
$0.03−$0.00 (−8.82%)
CERO · Last trade
Prev Close
$0.03
Range (30d)
$0.03 – $0.04
Recent Filings
- 8-K242.7 KBCERO THERAPEUTICS HOLDINGS, INC.Mar 10, 6:44 PM ET·0001213900-26-025817
- 8-K387.4 KBCERO THERAPEUTICS HOLDINGS, INC.Feb 13, 4:35 PM ET·0001213900-26-016474
- 8-K7.9 MBCERO THERAPEUTICS HOLDINGS, INC.Feb 4, 9:12 AM ET·0001213900-26-011844
- 8-K233.3 KBCERO THERAPEUTICS HOLDINGS, INC.Feb 3, 5:15 PM ET·0001213900-26-011587
- 8-K12.2 MBCERO THERAPEUTICS HOLDINGS, INC.Jan 7, 4:37 PM ET·0001213900-26-002187
- 8-K259.6 KBCERO THERAPEUTICS HOLDINGS, INC.Dec 19, 4:49 PM ET·0001213900-25-123912
- S-120.2 MBCERO THERAPEUTICS HOLDINGS, INC.Dec 5, 5:12 PM ET·0001213900-25-118817
- 8-K956.4 KBCERO THERAPEUTICS HOLDINGS, INC.Dec 2, 8:30 AM ET·0001213900-25-116971
- 10-Q9.4 MBCERO THERAPEUTICS HOLDINGS, INC.Nov 19, 4:10 PM ET·0001213900-25-112619
- 8-K264.2 KBCERO THERAPEUTICS HOLDINGS, INC.Oct 29, 7:27 PM ET·0001213900-25-103661
Insiders
10- ATWOOD BRIAN GDirector
- Byrnes MichaelDirector
- Carter Charles RossChief Financial Officer
- Corey DanielDirector, Chief Technical Officer
- Ehrlich Christopher BDirector, Chairman and CEO
- Fisher Douglas CarlPresident
- Geffken Daniel E.Chief Financial Officer
- Kosacz BarbaraDirector
- KUCHARCHUK ANDREW ALBERTChief Financial Officer
- LAPORTE KATHLEENDirector
Tickers
Addresses
business
201 HASKINS WAY SUITE 230
SOUTH SAN FRANCISCO, CA, 94080
mailing
201 HASKINS WAY SUITE 230
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- CERO THERAPEUTICS HOLDINGS, INC.2026-03-11
- PHOENIX BIOTECH ACQUISITION CORP.2024-02-14